Alvotech and Dr Reddy’s Laboratories partner to develop biosimilar for Keytruda targeting global markets Read more
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025 Read more